Assessment and Clinical Management of Patients With Atopic Dermatitis Undergoing Patch Testing: Recommendations From an International Electronic Delphi Consensus

1. Liu H . Effect of skin barrier on atopic dermatitis. Dermatitis. 2025;36(1):37–45; doi: 10.1089/derm.2024.0106

2. Sidbury R , Alikhan A , Bercovitch L , et al. Executive summary: American Academy of Dermatology guidelines of care for the management of atopic dermatitis in adults with topical therapies. J Am Acad Dermatol. 2023;89(1):128–129; doi: 10.1016/j.jaad.2022.08.068

3. Davis DMR , Drucker AM , Alikhan A , et al. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies. J Am Acad Dermatol. 2024;90(2):e43–e56; doi: 10.1016/j.jaad.2023.08.102

4. Rustemeyer T , Van Hoogstraten IM , Von Blomberg BM , et al. Mechanisms of allergic contact dermatitis. Occupational Dermatology. 2012:113–46.

5. Johansen JD , Aalto-Korte K , Agner T , et al. European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice. Contact Dermatitis. 2015;73(4):195–221; doi: 10.1111/cod.12432

6. de Waard-van der Spek FB , Darsow U , Mortz CG , et al. EAACI position paper for practical patch testing in allergic contact dermatitis in children. Pediatr Allergy Immunol. 2015;26(7):598–606; doi: 10.1111/pai.12463

7. Ophaug S , Schwarzenberger K . Pitfalls in patch testing: Minimizing the risk of avoidable false-negative reactions. Dermatol Clin. 2020;38(3):293–300; doi: 10.1016/j.det.2020.02.007

8. Gittler JK , Krueger JG , Guttman-Yassky E . Atopic dermatitis results in intrinsic barrier and immune abnormalities: Implications for contact dermatitis. J Allergy Clin Immunol. 2013;131(2):300–313; doi: 10.1016/j.jaci.2012.06.048

9. Correa Da Rosa J , Malajian D , Shemer A , et al. Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin. J Allergy Clin Immunol. 2015;135(3):712–720; doi: 10.1016/j.jaci.2014.11.017

10. Uehara M , Sawai T . A longitudinal study of contact sensitivity in patients with atopic dermatitis. Arch Dermatol. 1989;125(3):366–368.

11. Thyssen JP , McFadden JP , Kimber I . The multiple factors affecting the association between atopic dermatitis and contact sensitization. Eur J Immunol. 2014;69(1):28–36; doi: 10.1111/all.12358

12. Newell L , Polak ME , Perera J , et al. Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis. J Invest Dermatol. 2013;133(10):2372–2380; doi: 10.1038/jid.2013.148

13. Hamann CR , Hamann D , Egeberg A , et al. Association between atopic dermatitis and contact sensitization: A systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):70–78; doi: 10.1016/j.jaad.2017.02.001

14. Johnson H , Aquino MR , Snyder A , et al. Prevalence of allergic contact dermatitis in children with and without atopic dermatitis: A multicenter retrospective case-control study. J Am Acad Dermatol. 2023;89(5):1007–1014; doi: 10.1016/j.jaad.2023.06.048

15. Sandler M , Chen LC , Yu J . The association between atopic dermatitis and allergic contact dermatitis: A cross-sectional analysis using the All of Us research program. Dermatitis. 2025;36(1):e102-3–e103.

16. Trimeche K , Lahouel I , Belhadjali H , et al. Contact allergy in atopic dermatitis: A prospective study on prevalence, incriminated allergens and clinical insights. Contact Dermatitis. 2024;90(5):514–519; doi: 10.1111/cod.14494

17. Chicharro P , Munera-Campos M , Zaragoza-Ninet V , et al. Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC). Contact Dermatitis. 2024;91(5):404–411; doi: 10.1111/cod.14672

18. Silverberg JI , Hou A , Warshaw EM , et al. Prevalence and trend of allergen sensitization in adults and children with atopic dermatitis referred for patch testing, North American Contact Dermatitis Group data 2001-2016. J Allergy Clin Immunol Pract. 2021;9(7):2853–2866.e14; doi: 10.1016/j.jaip.2021.03.028

19. Chen JK , Jacob SE , Nedorost ST , et al. A pragmatic approach to patch testing atopic dermatitis patients: Clinical recommendations based on expert consensus opinion. Dermatitis. 2016;27(4):186–192; doi: 10.1097/DER.0000000000000208

20. Wu PA , Wu J , Liu R , et al. Epidermal spongiotic Langerhans cell collections, but not eosinophils, are a clue to the diagnosis of allergic contact dermatitis: A series of 170 clinically- and patch test-confirmed cases. J Am Acad Dermatol. 2025;92(4):853–860; doi: 10.1016/j.jaad.2024.11.062

21. Fitch K , Bernstein SJ , Aguilar MD , et al. The RAND/UCLA Appropriateness Method User’s Manual. Rand Corp Santa Monica: CA; 2001.

22. Pimentel MA , Li MM , Noe MH , et al. Features that define clinical severity of ulcerative pyoderma gangrenosum: A Delphi consensus study of experts and patients on behalf of the US Medical Dermatology Society. Br J Dermatol. 2023;188(4):566–568; doi: 10.1093/bjd/ljac137

23. Brüggen MC , Walsh S , Ameri MM , DRESS Delphi consensus group. et al.; Management of adult patients with drug reaction with eosinophilia and systemic symptoms: A Delphi-based international consensus. JAMA Dermatol. 2024;160(1):37–44; doi: 10.1001/jamadermatol.2023.4450

24. Maverakis E , Ma C , Shinkai K , et al. Diagnostic criteria of ulcerative pyoderma gangrenosum a Delphi consensus of international experts. JAMA Dermatol. 2018;154(4):461–466; doi: 10.1001/jamadermatol.2017.5980

25.R Core Team. (2025). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. Available from: https://www.R-project.org/

26. Lee EE , Maibach HI . Is contact allergy in man lifelong? An overview of patch test follow‐ups. Contact Dermatitis. 2001;44(3):137–139.

27. Garg V , Brod B , Gaspari AA . Patch testing: Uses, systems, risks/benefits, and its role in managing the patient with contact dermatitis. Clin Dermatol. 2021;39(4):580–590; doi: 10.1016/j.clindermatol.2021.03.005

28. Veverka KK , Davis MDP . Dubiously doubtful: An exploration of the literature concerning doubtful, macular erythema, “?+,” and +/Patch Test Reactions. Dermatitis. 2020;31(1):36–41; doi: 10.1097/DER.0000000000000533

29. Viggiano T , Yiannias JA , Yang YW . A retrospective review of late delayed positive patch testing greater than day 8 at Mayo Clinic from 2001 to 2020. Dermatitis. 2022;33(6):411–416; doi: 10.1097/DER.0000000000000951

30. Houle MC , DeKoven JG , Atwater AR , et al. North American Contact Dermatitis Group patch test results: 2021–2022. Dermatitis. 2025;36(5):464–476; doi: 10.1089/derm.2024.0474

31. Reeder MJ , Nihal A , Aravamuthan SR , et al. Allergic or not: Final interpretation of doubtful patch test reactions from the North American Contact Dermatitis Group, 2019–2020. Dermatitis. 2024;35(2):138–143; doi: 10.1089/derm.2023.0285

32. Arora P , Brumley C , Hylwa S . Clinical relevance of doubtful reactions in patch testing: A single-centre retrospective study. Contact Dermatitis. 2024;90(6):607–612; doi: 10.1111/cod.14526

33. Scheman A , Ruggiero JL , Kerchinsky L , et al. Contact allergy cross-reactions and thresholds: A review. Dermatitis. 2022;33(2):106–109; doi: 10.1097/DER.0000000000000798

34. Scheman A , Hipolito R , Severson D , et al. Contact allergy cross-reactions: Retrospective clinical data and review of the literature. Dermatitis. 2017;28(2):128–140; doi: 10.1097/DER.0000000000000254

35. Shi Y , Nedorost S , Scheman L , et al. Propolis, colophony, and fragrance cross-reactivity and allergic contact dermatitis. Dermatitis. 2016;27(3):123–126; doi: 10.1097/DER.0000000000000186

36. Korkmaz P , Boyvat A . Effect of patch testing on the course of allergic contact dermatitis and prognostic factors that influence outcomes. Dermatitis. 2019;30(2):135–141; doi: 10.1097/DER.0000000000000452

37. Hanson JL , Warshaw EM . Contact allergy to surfactants in a hypoallergenic liquid cleanser. Dermatitis. 2015;26(6):284–286; doi: 10.1097/DER.0000000000000141

38. Nedorost S . A sticky mess— are moisturizers overused in dermatitis care? J Am Acad Dermatol. 2024;91(6):1171–1176; doi: 10.1016/j.jaad.2024.07.1485

39. Marcelino J , Giménez-Arnau AM . Impact of cosmetics and cleansers in atopic dermatitis—how to advise patients. Curr Treat Options Allergy. 2024;11(2):62–76; doi: 10.1007/s40521-024-00360-1

40. Hiranput S , McAllister L , Hill G , et al. Do hypoallergenic skincare products contain fewer potential contact allergens? Clin Exp Dermatol. 2024;49(4):386–387.

41. Nassif A , Chan SC , Storrs FJ , et al. Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis. Arch Dermatol. 1994;130(11):1402–1407; doi: 10.1001/archderm.1994.01690110068008

42. Jakasa I , Verberk MM , Esposito M , et al. Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J Invest Dermatol. 2007;127(1):129–134; doi: 10.1038/sj.jid.5700582

43.National Eczema Association. 8 skincare ingredients to avoid if you have eczema, according to dermatologists. 2022. Available from: https://nationaleczema.org/blog/8-skincare-ingredients-to-avoid/ [Last accessed: May 5, 2025].

44. Hannuksela M , Salo H . The repeated open application test (ROAT). Contact Dermatitis. 1986;14(4):221–227; doi: 10.1111/j.1600-0536.1986.tb01229.x

45. Baruffi FY , Venkatesh KP , Nelson KN , et al. Systemic contact dermatitis: A review. Dermatol Clin. 2020;38(3):379–388; doi: 10.1016/j.det.2020.02.008

46. Scott JF , Conic RRZ , Kim IY , et al. Atopy and sensitization to allergens known to cause systemic contact dermatitis. Dermatitis. 2019;30(1):62–66; doi: 10.1097/DER.0000000000000436

47. Scheman A , Cha C , Jacob SE , et al. Food avoidance diets for systemic, lip and oral contact allergy: An American Contact Alternatives Group article. Dermatitis. 2012;23(6):248–257; doi: 10.1097/DER.0b013e31827658ed

48. Mislankar M , Zirwas MJ . Low-nickel diet scoring system for systemic nickel allergy. Dermatitis. 2013;24(4):190–195; doi: 10.1097/DER.0b013e3182937e81

49. Scheman A , Rakowski EM , Chou V , et al. Balsam of Peru: Past and future. Dermatitis. 2013;24(4):153–160; doi: 10.1097/DER.0b013e31828afab2

50. Ahuja K , Issa CJ , Nedorost S , et al. Is food-triggered atopic dermatitis a form of systemic contact dermatitis? Clin Rev Allergy Immunol. 2024;66(1):1–13; doi: 10.1007/s12016-023-08977-x

51. Veien NK , Hattel T , Laurberg G . Low nickel diet: An open, prospective trial. J Am Acad Dermatol. 1993;29(6):1002–1007; doi: 10.1016/0190-9622(93)70281-W

52. Fisher AA . The prevention and management of the angry back (excited skin syndrome [ESS]) in patch testing: Part II. Cutis. 1997;59(1):11–12.

53. Schalock PC , Dunnick CA , Nedorost S , American Contact Dermatitis Society Core Allergen Series Committee. et al.; American Contact Dermatitis Society Core Allergen Series: 2020 update. Dermatitis. 2020;31(5):279–282; doi: 10.1097/DER.0000000000000621

54.Thin-Layer Rapid Use Epicutaneous Patch Test (T.R.U.E. Test). [package insert]. SmartPractice: Phoenix, AZ; 2017.

55. Mufti A , Lu JD , Sachdeva M , et al. Patch testing during immunosuppressive therapy: A systematic review. Dermatitis. 2021;32(6):365–374; doi: 10.1097/DER.0000000000000726

56. de Wijs LEM , van der Waa JD , Nijsten T , et al. Effects of dupilumab treatment on patch test reactions: A retrospective evaluation. Clin Exp Allergy. 2021;51(7):959–967; doi: 10.1111/cea.13892

57. Bocquel S , Soria A , Raison-Peyron N , et al. Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study. J Am Acad Dermatol. 2024;90(3):512–520; doi: 10.1016/j.jaad.2023.10.029

58. Stout M , Silverberg JI . Variable impact of dupilumab on patch testing results and allergic contact dermatitis in adults with atopic dermatitis. J Am Acad Dermatol. 2019;81(1):157–162; doi: 10.1016/j.jaad.2019.03.020

59. Raffi J , Suresh R , Botto N , et al. The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: A retrospective chart review. J Am Acad Dermatol. 2020;82(1):132–138; doi: 10.1016/j.jaad.2019.09.028

60. Nedorost S , Wu P , Yu J , et al. To patch or not to patch on dupilumab: That is the question. J Am Acad Dermatol. 2025;92(4):e113–e114; doi: 10.1016/j.jaad

61. O’Hern K , Chapman MS , Zug KA , et al. Expert opinion on patch testing while receiving immunomodulatory therapy: Results of an international survey study. Dermatitis. 2022;33(4):e51–e3; doi: 10.1097/DER.0000000000000837

62. Sandler M , Adler BL , Atwater AR , et al. Updated expert opinion guidelines regarding the effects of immunosuppressive agents on patch testing. J Am Acad Dermatol. 2025;92(6):1383–1385.

63. Pootongkam S , Havele SA , Orillaza H , et al. Atopy patch tests may identify patients at risk for systemic contact dermatitis. Immun Inflamm Dis. 2020;8(1):24–29; doi: 10.1002/iid3.280

64. Kerschenlohr K , Darsow U , Burgdorf WHC , et al. Lessons from atopy patch testing in atopic dermatitis. Curr Allergy Asthma Rep. 2004;4(4):285–289; doi: 10.1007/s11882-004-0072-7

65. Braunberger T , Lynn D , Reimer C , et al. Disease severity and quality of life measurements in contact dermatitis: A systematic review 2005–2015. Dermatitis. 2016;27(6):362–371; doi: 10.1097/DER.0000000000000235

66. Raffi J , Elaine Allen I , Botto N . Validating responsiveness of a quality-of-life instrument for allergic contact dermatitis. Dermatitis. 2020;31(3):209–214; doi: 10.1097/DER.0000000000000542

67. Kadyk DL , McCarter K , Achen F , et al. Quality of life in patients with allergic contact dermatitis. J Am Acad Dermatol. 2003;49(6):1037–1048; doi: 10.1016/S0190-9622(03)02112-1

68. Steuer MS , Botto NC . Patient reported improvement after patch testing and allergen avoidance counseling: A retrospective analysis. Dermatol Ther (Heidelb). 2018;8(3):435–440; doi: 10.6084/m9.figshare.6682958

69. Jacobson ME , Leshem YA , Apfelbacher C , Harmonising Outcome Measures for Eczema (HOME) initiative. et al.; Measuring signs of atopic dermatitis in clinical practice: A HOME-CP consensus statement. JAMA Dermatol. 2024;160(8):878–886; doi: 10.1001/jamadermatol.2024.1162

70. Leshem YA , Chalmers JR , Apfelbacher C , Harmonising Outcome Measures for Eczema (HOME) initiative. et al.; Measuring atopic eczema control and itch intensity in clinical practice: A consensus statement from the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative. JAMA Dermatol. 2022;158(12):1429–1435; doi: 10.1001/jamadermatol.2022.4211